In this trial, some subjects will receive the active investigational medication, while other subjects will receive placebo (a capsule with no active medication). All subjects will have at least a 4 in 5 chance of receiving active investigational medication. Regardless of whether someone receives the active investigational medication or placebo, the level of trial-related care she receives will be the same.